期刊文献+

基于基因修饰细胞系的生物检定法研究进展 被引量:2

Research progress of genetically modified cell-based bioassays
下载PDF
导出
摘要 以药物的作用机制为基础,采用细胞与分子生物学技术构建特定基因修饰细胞系并开发相应的检测方法,可用于相关产品的生物检定。这种基于基因修饰细胞系的生物检定法在药物的质量控制领域具有广泛的应用前景。本文探讨了基因修饰细胞系的构建策略及检测方法的基本原理,并概述了基于基因修饰细胞系的生物检定法在重组蛋白类、疫苗类、基因治疗类等不同产品质量评价中的研究进展及应用情况。 Based on the mechanism of action of drugs,specific gene modified cell lines are constructed using cell and molecular biology technologies,and corresponding test methods are developed,which can be used for biological assays of related products.These genetically modified cell-based bioassays have a wide application prospect in the field of pharmaceutical quality control.In this paper,the construction strategies of genetically modified cell lines and the basic principles of detection methods are discussed,and the research progress and application of genetically modified cell-based bioassays in the quality evaluation of recombinant proteins,vaccines,and gene therapy products are summarized.
作者 于雷 周勇 王军志 YU Lei;ZHOU Yong;WANG Junzhi(National Institutes for Food and Drug Control,Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products,Beijing 100050,China)
出处 《中国药品标准》 CAS 2022年第2期101-107,共7页 Drug Standards of China
基金 国家药典委员会国家药品标准提高项目课题(2019S06)。
关键词 基因修饰细胞系 生物检定法 细胞法 报告基因法 活性/效价测定 genetically modified cells bioassays cell-based bioassays reporter gene assays bioactivity/potency determination
  • 相关文献

参考文献6

二级参考文献40

  • 1袁力勇,饶春明,郭莹,李响,刘长暖,张翊,王军志.重组人纽兰格林生物学活性检测方法及质控标准[J].中国生物制品学杂志,2004,17(6):374-376. 被引量:5
  • 2安祺,董关木,刘文雪,杨立宏,孔艳.SARS冠状病毒空斑技术的建立和应用[J].中国生物制品学杂志,2004,17(6):400-402. 被引量:7
  • 3谭兴容,王毅,杨刚毅.Exendin-4与糖尿病治疗[J].重庆医学,2006,35(10):904-906. 被引量:8
  • 4李克坚,梁成罡,杨勇,张慧,杨化新.重组促胰岛素分泌素生物学活性测定方法的研究[J].药物分析杂志,2006,26(12):1691-1693. 被引量:4
  • 5Lau SC, Rosa DI), Jayson G. Technology evaluation: VEGF Trap (cancer), regeneron/sanofi-aventis. Curr Opin Mol Ther, 2005, 7 (5): 493-501.
  • 6Holash J, Davis S, Papadopoulos N, et al. VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc Natl Acad Sci USA, 2002, 99 (17): 11393-11398.
  • 7Riely GJ, Miller VA. Vascular endothelial growth factor trap in non small cell lung cancer. Clin Cancer Res, 2007, 13 (15pt2): s4623-s4627.
  • 8Do DV, Nguyen QD, Shah SM, et al. An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic maeular oedema. Br J Ophthalmol, 2009, 93 (2): 144-149.
  • 9Kaiser PK. Vascular endothelial growth factor Trap-Eye for diabetic macular oedema. Br J Ophthalmol, 2009, 93 (2): 135-136.
  • 10Aflibercept: AVE 0005, AVE 005, AVE0005, VEGF Trap-Regeneron, VEGF Trap (RIR2), VEGF Trap-Eye. Drugs RD, 2008, 9 (4): 261-269.

共引文献67

同被引文献20

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部